GenBio Newsroom Press Releases

Published on September 4, 2025 - 13:45 GMT

GenBio Announces Provisional Patent for Inflamoxil, a Next-Generation Anti-Inflammatory Therapy

Next-generation therapy aims to redefine treatment for inflammatory conditions ALISO VIEJO, CA, UNITED STATES, September 4, 2025 /⁨EINPresswire.com⁩/ -- GenBio, a biotechnology company focused on advancing novel therapies for chronic inflammation, today …

Distribution channels: Banking, Finance & Investment Industry, Conferences & Trade Fairs ...

Published on September 2, 2025 - 14:15 GMT

GenBio CSO Highlights Groundbreaking Research on Anthocyanins and Their Potential for Global Health and Food Security

ALISO VIEJO, CA, UNITED STATES, September 2, 2025 /⁨EINPresswire.com⁩/ -- GenBio today announced that its Chief Scientific Officer shared new insights into the powerful role of anthocyanins, natural plant metabolites responsible for the vibrant red, pink, …

Distribution channels: Banking, Finance & Investment Industry, Consumer Goods ...

Published on August 29, 2025 - 13:30 GMT

GenBio Announces Filing of Trademark Application for Imflamoxil

ALISO VIEJO, CA, UNITED STATES, August 29, 2025 /⁨EINPresswire.com⁩/ -- GenBio Announces Filing of Trademark Application for Imflamoxil – GenBio, a biotechnology company dedicated to developing innovative therapies for immune and inflammatory …

Distribution channels: Banking, Finance & Investment Industry, Consumer Goods ...

Published on August 27, 2025 - 14:15 GMT

GenBio Is Excited to share CSO's Research on the Gut-Liver Axis

Chronic liver disease, including fatty liver disease, causes around 2 million deaths each year. ALISO VIEJO, CA, UNITED STATES, August 27, 2025 /⁨EINPresswire.com⁩/ -- GenBio's CSO Professor Lindsay Brown's research on Chronic liver disease, …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on June 30, 2025 - 14:15 GMT

GenBio CSO Professor Lindsay Brown Drills Down into the Autism Spectrum Disorder

The Global Burden of Disease 2021 report estimated that 1 in 127 people or 61.8 million were on the autism spectrum (ASD) globally ALISO VIEJO, CA, UNITED STATES, June 30, 2025 /⁨EINPresswire.com⁩/ -- The Global Burden of Disease 2021 report estimated …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on June 16, 2025 - 14:15 GMT

GenBio Addresses Maintaining Glucose Homeostasis

Hormonal and neural regulatory mechanisms that maintain blood glucose levels within a very narrow range ALISO VIEJO, CA, UNITED STATES, June 16, 2025 /⁨EINPresswire.com⁩/ -- Glucose from a diet is the major energy source for humans and other mammals. …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on June 9, 2025 - 13:00 GMT

GenBio Inc. Shares Valuable Information on Protecting and Repairing the Gastrointestinal Tract

Globally, 38.4% of prevalent diseases had a digestive etiology, representing 2.9 billion cases ALISO VIEJO, CA, UNITED STATES, June 9, 2025 /⁨EINPresswire.com⁩/ -- Changes in gut bacteria lead to damaged structure and function of the gastrointestinal …

Distribution channels: Banking, Finance & Investment Industry, Conferences & Trade Fairs ...

Published on June 2, 2025 - 14:15 GMT

GenBio CSO Addresses Protecting the Kidneys

Approximately 850 million people worldwide are estimated to have kidney disease ALISO VIEJO, CA, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Chronic kidney disease involves the gradual loss of the ability of the kidney to remove waste products …

Distribution channels: Banking, Finance & Investment Industry, Conferences & Trade Fairs ...

Published on May 27, 2025 - 13:00 GMT

GenBio Aims to Address Bone Loss and Repair

Osteoporosis affects approximately 6.3% of men over the age of 50 and 21.2% of women over the same age range globally ALISO VIEJO, CA, UNITED STATES, May 27, 2025 /⁨EINPresswire.com⁩/ -- Increasing Bone Repair Healthy humans undergo continual bone …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...

Published on May 21, 2025 - 12:30 GMT

GenBio Inc. Digging Deep into Inflammatory Diseases

Chronic inflammation: Cause of more than half of deaths worldwide ALISO VIEJO, CA, UNITED STATES, May 21, 2025 /⁨EINPresswire.com⁩/ -- Inflammation is the physiological process of releasing specific chemicals to fight infections and heal damaged tissues. …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...

Published on May 13, 2025 - 13:45 GMT

GenBio CSO Dives Deep into the Subject of Protecting the Heart and Blood Vessels

The heart and blood vessels are essential! ALISO VIEJO, CA, UNITED STATES, May 13, 2025 /⁨EINPresswire.com⁩/ -- Protecting the Heart and Blood Vessels The heart and blood vessels are essential since all living cells require an adequate supply of oxygen …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...

Published on May 9, 2025 - 16:58 GMT

GenBio is Researching the Obesity Epidemic Affecting Over One Billion People Worldwide

ALISO VIEJO, CA, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The increase in the prevalence of obesity over the last fifty years has been described as a pandemic that increases the risk of many diseases, including cardiovascular disease, diabetes, …

Distribution channels: Banking, Finance & Investment Industry, Conferences & Trade Fairs ...

Published on May 2, 2025 - 13:45 GMT

GenBio Is excited to share how functional foods improve liver structure and function

Diet plays a key role in maintaining liver health ALISO VIEJO, CA, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Functional foods improve liver structure and function Fats are an important part of the human diet as a major source of energy. Around …

Distribution channels: Banking, Finance & Investment Industry, Education ...

Published on April 30, 2025 - 14:00 GMT

GenBio's Chief Science Officer Professor Lindsay Brown Investigates the Microbiome-Gut-Brain Axis

"All disease begins in the gut." Hippocrates ALISO VIEJO, CA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- GenBio’s Chief Scientific Officer is internationally recognized for investigating the health impact of chronic diseases of …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on April 25, 2025 - 15:43 GMT

GenBio Is Pleased to Share the Latest Neuroprotective Research in Alzheimer’s disease (AD)

Crossing The Blood-Brain Barrier (BBB) The Power of Purple! ALISO VIEJO, CA, UNITED STATES, April 25, 2025 /⁨EINPresswire.com⁩/ -- Alzheimer’s disease is a progressive neurodegenerative disorder where patients suffer a gradual deterioration of memory and …

Distribution channels: Banking, Finance & Investment Industry, Conferences & Trade Fairs ...

Published on August 27, 2024 - 13:00 GMT

GenBio Inc, is Pleased to Announce the Filing of a Provisional Patent for its Identified Therapeutic Compound

This marks a major milestone for GenBio Inc and its ongoing efforts to revolutionize the future of medicine. ALISO VIEJO, CA, UNITED STATES, August 27, 2024 /⁨EINPresswire.com⁩/ -- GenBio Inc, a leading biotechnology company, has announced significant …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on August 1, 2024 - 13:00 GMT

GenBio Inc Partners with PharmaVentures to Accelerate Growth in the Biotechnology Industry

GenBio Inc, has engaged PharmaVentures, a premier transaction advisory firm with over 30 years of experience in Biotechnology M&A deals ALISO VIEJO, CA, UNITED STATES, August 1, 2024 /⁨EINPresswire.com⁩/ -- GenBio Inc, an early-stage biotechnology …

Distribution channels: Banking, Finance & Investment Industry, Food & Beverage Industry ...

Published on July 30, 2024 - 14:00 GMT

GenBio Partners with Patent Attorney Michael P. Burns, Esq. to spearhead its IP program

This partnership marks a significant step for GenBio as they continue to expand their patent portfolio and protect their innovative drug discovery program. ALISO VIEJO, CA, UNITED STATES, July 30, 2024 /⁨EINPresswire.com⁩/ -- GenBio, a leading …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on May 2, 2024 - 14:00 GMT

Nurtific's Strategic Partner Blue Star OTC:BSTO Signs Agreement with Engineering Powerhouse

Blue Star Opportunities (OTCMKTS:BSTO) ALISO VIEJO, CA, UNITED STATES, May 2, 2024 /⁨EINPresswire.com⁩/ -- Blue Star Opportunities Signs Agreement with Engineering Powerhouse Blue Star Opportunities Corp. (The "Company") (OTC: BSTO), …

Distribution channels: Banking, Finance & Investment Industry, Culture, Society & Lifestyle ...

Published on April 24, 2024 - 15:12 GMT

Nutrific Grants Worldwide Rights to Blue Star Opportunities for Innovative Immune System Optimization Products

Blue Star Opportunities $BSTO acquires worldwide rights to innovative Immune System Optimization products in Natural Healthcare Sector. Blue Star Opportunities (OTCMKTS:BSTO) ALISO VIEJO, CA, UNITED STATES, April 24, 2024 /⁨EINPresswire.com⁩/ -- Blue …

Distribution channels: Banking, Finance & Investment Industry, Consumer Goods ...

The Newsroom of GenBio Inc.